Personalized cancer vaccines: clinical landscape, challenges, and opportunities

CS Shemesh, JC Hsu, I Hosseini, BQ Shen, A Rotte… - Molecular Therapy, 2021 - cell.com
Tremendous innovation is underway among a rapidly expanding repertoire of promising
personalized immune-based treatments. Therapeutic cancer vaccines (TCVs) are attractive …

Computational pharmaceutics-A new paradigm of drug delivery

W Wang, Z Ye, H Gao, D Ouyang - Journal of Controlled Release, 2021 - Elsevier
In recent decades pharmaceutics and drug delivery have become increasingly critical in the
pharmaceutical industry due to longer time, higher cost, and less productivity of new …

Emerging artificial intelligence (AI) technologies used in the development of solid dosage forms

J Jiang, X Ma, D Ouyang, RO Williams III - Pharmaceutics, 2022 - mdpi.com
Artificial Intelligence (AI)-based formulation development is a promising approach for
facilitating the drug product development process. AI is a versatile tool that contains multiple …

Machine learning and pharmacometrics for prediction of pharmacokinetic data: differences, similarities and challenges illustrated with rifampicin

L Keutzer, H You, A Farnoud, J Nyberg, SG Wicha… - Pharmaceutics, 2022 - mdpi.com
Pharmacometrics (PM) and machine learning (ML) are both valuable for drug development
to characterize pharmacokinetics (PK) and pharmacodynamics (PD). Pharmacokinetic …

How can machine learning and multiscale modeling benefit ocular drug development?

N Wang, Y Zhang, W Wang, Z Ye, H Chen, G Hu… - Advanced Drug Delivery …, 2023 - Elsevier
The eyes possess sophisticated physiological structures, diverse disease targets, limited
drug delivery space, distinctive barriers, and complicated biomechanical processes …

Opportunities and challenges of physiologically based pharmacokinetic modeling in drug delivery

W Wang, D Ouyang - Drug Discovery Today, 2022 - Elsevier
Highlights•PBPK modeling bridges drug properties and PK behaviours in drug discovery
and development.•The PBPK is often used in oral formulation development, to address …

Artificial intelligence in toxicology and pharmacology

S Nasnodkar, B Cinar, S Ness - Journal of Engineering …, 2023 - journal.send2sub.com
Methods that utilize machine learning and artificial intelligence have transformed a wide
variety of fields, including the field of toxicology. Physiologically based pharmacokinetic …

Systems biology of angiogenesis signaling: Computational models and omics

Y Zhang, H Wang, RHM Oliveira… - WIREs mechanisms …, 2022 - Wiley Online Library
Angiogenesis is a highly regulated multiscale process that involves a plethora of cells, their
cellular signal transduction, activation, proliferation, differentiation, as well as their …

Fast screening of covariates in population models empowered by machine learning

E Sibieude, A Khandelwal, JS Hesthaven… - … of pharmacokinetics and …, 2021 - Springer
One of the objectives of Pharmacometry (PMX) population modeling is the identification of
significant and clinically relevant relationships between parameters and covariates. Here …

Combination of in vivo phage therapy data with in silico model highlights key parameters for pneumonia treatment efficacy

R Delattre, J Seurat, F Haddad, TT Nguyen… - Cell Reports, 2022 - cell.com
The clinical (re) development of bacteriophage (phage) therapy to treat antibiotic-resistant
infections faces the challenge of understanding the dynamics of phage-bacteria interactions …